Organigram Global to Acquire Aurora Cannabis for CA$7.80 per Common Share

Organigram Global (OGI) and Aurora Cannabis (ACB) agreed to a merger. Organigram will acquire Aurora for CA$7.80 per share. The deal is subject to regulatory approvals and shareholder votes.

Original reporting
Published Nov 3, 2026, 4:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 5:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Organigram Global to Acquire Aurora Cannabis for CA$7.80 per Common Share — source image
Decision brief

The 30-second read

High
01

Why it matters

For the target, the offer price is the primary near-term driver. For the acquirer, the market will weigh strategic rationale against integration and closing risks.

02

Market read

This is a headline M&A deal term that typically triggers immediate repricing and deal-arbitrage positioning in both buyer and target shares.

03

What to watch

Traders will need deal conditions, expected closing timeline, and any financing structure details, which are not present in the provided body excerpt.

Relevance 9/10Novelty 9/10Timing: deal announcement reported today

Background

The article headline states Organigram Global and Aurora Cannabis entered an arrangement agreement for a cash acquisition at CA$7.80 per common share.

Market effects

Could shift sentiment across Canadian cannabis M&A, signaling consolidation and potential revaluation of distressed peers.

Most direct impact is on Canadian-listed cannabis equities and deal-arbitrage flows in Canada.

Limited global spillover beyond cannabis M&A expectations unless the deal changes broader industry financing conditions.

Counterpoint

Offer price may already be partially priced in, and deal risk (financing, regulatory approvals, shareholder votes) could cap upside or increase volatility.

Key entities

  • Organigram Global

    Named as the buyer in an arrangement agreement to acquire Aurora Cannabis.

  • Aurora Cannabis

    Named as the company to be acquired under the arrangement agreement.

Related articles

$OGIHighAI 9/10

Organigram outbids Curaleaf with C$561M deal for Aurora Cannabis

Organigram Holdings has agreed to acquire Aurora Cannabis for C$561 million, a 21% higher offer than Curaleaf's. The C$7.80-per-share deal is a 93% premium to Aurora's unaffected share price. Aurora shares rose nearly 20% post-announcement. The combined company expects C$50M in annual synergies. Aurora's board recommends rejecting Curaleaf's bid.

$ACBHighAI 9/10

Organigram Strikes A Deal to Acquire Aurora Cannabis

Organigram will acquire Aurora Cannabis for C$561 million (US$402 million), a 93% premium to Aurora's August 10 share price. Aurora shareholders will own 35% of the combined company. British American Tobacco will fund part of the deal. The acquisition aims to strengthen Organigram's position in the European cannabis market. Aurora's shares rose 21%, while Organigram's fell 2.6%.

$OGIHighAI 9/10

Organigram to Acquire Aurora Cannabis in C$561 Million Deal, Topping Curaleaf’s Hostile Takeover Offer

Organigram will acquire Aurora Cannabis for C$561M (US$398M) at C$7.80 per share, a 93% premium over Aurora's unaffected price and 21% premium over Curaleaf's offer. The deal, approved by both boards, is expected to close in January 2027. Aurora shareholders can choose cash, stock, or a mix. British American Tobacco is financing part of the acquisition.